Al-Razi Medical Company (TADAWUL:9572)
Saudi Arabia · Delayed Price · Currency is SAR 26.70
-0.22 (-0.82%)
Aug 13, 2026, 2:07 PM AST
Al-Razi Medical Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 76.4 | 74.38 | 61.35 | 61.33 | 52.39 | 45.19 | |
Revenue Growth | 19.12% | 21.24% | 0.03% | 17.07% | 15.95% | - |
Cost of Revenue | 56.63 | 55.25 | 44.95 | 44.03 | 36.42 | 32.23 |
Gross Profit | 19.77 | 19.14 | 16.4 | 17.3 | 15.97 | 12.95 |
Selling, General & Admin | 18.11 | 17.62 | 16.02 | 16 | 13.39 | 10.53 |
Other Operating Expenses | - | - | - | -0.27 | - | - |
Operating Expenses | 18.11 | 17.62 | 16.02 | 15.75 | 13.4 | 10.53 |
Operating Income | 1.66 | 1.52 | 0.38 | 1.55 | 2.57 | 2.42 |
Interest Expense | -0.76 | -0.82 | -0.51 | -0.48 | -0.3 | -0.37 |
Other Non Operating Income (Expenses) | 0.42 | 0.37 | 0.66 | - | 0.15 | 0.48 |
EBT Excluding Unusual Items | 1.33 | 1.06 | 0.53 | 1.08 | 2.43 | 2.53 |
Gain (Loss) on Sale of Assets | 0.01 | 0.01 | - | 0.01 | - | - |
Pretax Income | 1.34 | 1.07 | 0.53 | 1.09 | 2.43 | 2.53 |
Income Tax Expense | 0.21 | 0.25 | 0.35 | 0.4 | 0.41 | 0.37 |
Net Income | 1.12 | 0.82 | 0.18 | 0.69 | 2.01 | 2.16 |
Net Income to Common | 1.12 | 0.82 | 0.18 | 0.69 | 2.01 | 2.16 |
Net Income Growth | 298.45% | 365.96% | -74.36% | -65.95% | -6.87% | - |
Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 0.74 | 0.54 | 0.12 | 0.45 | 1.33 | 1.42 |
EPS (Diluted) | 0.74 | 0.54 | 0.12 | 0.45 | 1.33 | 1.42 |
EPS Growth | 298.45% | 365.96% | -74.36% | -65.95% | -6.87% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 4.27 | 3.85 | 1.1 | 1 | -0.64 | -2.82 |
Free Cash Flow Per Share | 2.81 | 2.53 | 0.72 | 0.66 | -0.42 | -1.86 |
Dividend Per Share | - | - | - | 1.587 | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 25.88% | 25.73% | 26.73% | 28.21% | 30.49% | 28.67% |
Operating Margin | 2.18% | 2.04% | 0.62% | 2.54% | 4.91% | 5.36% |
Profit Margin | 1.47% | 1.10% | 0.29% | 1.12% | 3.84% | 4.79% |
Free Cash Flow Margin | 5.59% | 5.17% | 1.79% | 1.63% | -1.22% | -6.25% |
EBITDA | 3.41 | 3.27 | 2.02 | 2.98 | 3.64 | 3.32 |
EBITDA Margin | 4.47% | 4.39% | 3.30% | 4.86% | 6.94% | 7.34% |
D&A For EBITDA | 1.75 | 1.75 | 1.64 | 1.43 | 1.06 | 0.9 |
EBIT | 1.66 | 1.52 | 0.38 | 1.55 | 2.57 | 2.42 |
EBIT Margin | 2.18% | 2.04% | 0.62% | 2.54% | 4.91% | 5.36% |
Effective Tax Rate | 16.02% | 23.31% | 66.80% | 36.82% | 16.94% | 14.61% |
Advertising Expenses | - | 0.13 | 0.1 | 0.27 | 0.09 | 0.08 |